Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
AbstractAccumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson’s disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, which include mitochondrial activity, as well as proteasome and autophagic degradation of proteins. Remarkably, these functions are also affected when the renewal of macromolecules and organelles becomes impaired during the normal aging process. As aging is considered a major risk factor for Parkinson’s disease, it is critical to explore its molecular and cellular implications in the context of the alpha-synuclein pathology. Here, we discuss similarities and differences between normal brain aging and Parkinson’s disease, with a particular emphasis on the nigral dopaminergic neurons, which appear to be selectively vulnerable to the combined effects of alpha-synuclein and aging. View Full-Text
Share & Cite This Article
Bobela, W.; Aebischer, P.; Schneider, B.L. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease. Biomolecules 2015, 5, 2675-2700.
Bobela W, Aebischer P, Schneider BL. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease. Biomolecules. 2015; 5(4):2675-2700.Chicago/Turabian Style
Bobela, Wojciech; Aebischer, Patrick; Schneider, Bernard L. 2015. "Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease." Biomolecules 5, no. 4: 2675-2700.